Dennis X Beringer

5PUBLICATIONS
12CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 17, 2025
Autologous profiling reveals inter-patient heterogeneity in Vδ2+γδTIL responses to glioblastoma driven by extracellular matrix-BTN3A axis.

Mara J T Nicolasen, Lucrezia Cde Gatti, Laia Gasull-Celades

|Dec 10, 2025
Cis- and trans-binding chimeric costimulatory receptors enhance T-cell fitness and tumor control.

Patricia Hernández-López, Caterina Riillo, Laia Gasull-Celades

|Jun 02, 2025
Disrupting the balance between activating and inhibitory receptors of γδT cells for effective cancer immunotherapy.

Dennis X Beringer, Trudy Straetemans, Susana Minguet

|Nov 27, 2023
Dual targeting of cancer metabolome and stress antigens affects transcriptomic heterogeneity and efficacy of engineered T cells.

Patricia Hernández-López, Eline van Diest, Peter Brazda

|Nov 24, 2021
Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds.

Eline van Diest, Patricia Hernández López, Angelo D Meringa

Pageof 1